fig1

Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches

Figure 1. Baseline gut microbiota differences between responders and non-responders to therapeutics used to treat IBD. IBD: Inflammatory bowel disease.